Posttransplant survival probability in patients with unrecognized IBMFS by gene group. (A) Telomere biology disorders. (B) Hematopoiesis disorders. (C) Ribosome biology disorders. (D) DNA damage response disorders. Kaplan-Meier curve comparing 3 groups of patients, those with a previously unrecognized IBMFS (green), carriers (red), and those with no variants (blue).